rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Steven A. Ledger

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Serina Therapeutics; Director, Crossroads Systems; Director, Broadcast International; Chairman of the Board, Graphon Corp/de; Director, Acorn Energy.

In numbers

Trades disclosed
19
Buys
2
Sells
0
Bought
$286K
Sold
$0
Companies
5
Companies where not an officer
3
First trade
29 Jul 2010
Last trade
26 May 2026
Last filed
27 May 2026

Companies traded

Where they are an officer
SER Serina TherapeuticsDirector, Officer · Biotechnology · last 26 May 20260 buys · 0 sells
Graphon Corp/deDirector, Officer · last 20 Dec 20121 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Crossroads SystemsDirector · last 30 Apr 20130 buys · 0 sells
Broadcast InternationalDirector · last 21 Feb 20131 buy · 0 sells
ACFN Acorn EnergyDirector · Professional Services · last 29 Jul 20100 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 May 2026filed 27 May 2026SER Serina TherapeuticsBiotechnologySEC FORM 4 Code A$19K10,100 at $1.93filing
26 May 2026filed 27 May 2026SER Serina TherapeuticsBiotechnologySEC FORM 4 Code A$19K10,100 at $1.93filing
21 May 2026filed 26 May 2026SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—380,825 at $0.00filing
21 May 2026filed 26 May 2026SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—380,825 at $0.00filing
3 Feb 2026filed 17 Feb 2026SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—230,100 at $0.00filing
3 Feb 2026filed 17 Feb 2026SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—230,100 at $0.00filing
28 Mar 2025filed 1 Apr 2025SER Serina TherapeuticsBiotechnologySEC FORM 4 Code J—95,730 at $0.00filing
9 Sep 2024filed 11 Sep 2024SER Serina Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—376,388 at $0.00filing
30 Apr 2013filed 2 May 2013Crossroads Systemsoption or derivativeSEC FORM 4 Code A$7,6393,237 at $2.36filing
21 Feb 2013filed 27 Feb 2013Broadcast InternationalSEC FORM 4 Code A$16K200,000 at $0.08filing
31 Dec 2012filed 27 Feb 2013Broadcast Internationaloption or derivativeSEC FORM 4 Code A$3,00037,500 at $0.08filing
20 Dec 2012filed 24 Jan 2013Graphon Corp/deoption or derivativeSEC FORM 4 Code A—300,000 at $0.00filing
30 Sep 2012filed 27 Feb 2013Broadcast Internationaloption or derivativeSEC FORM 4 Code A$4,00021,053 at $0.19filing
4 Apr 2012filed 5 Apr 2012Broadcast Internationaloption or derivativeSEC FORM 4 Code P—72,000 at $0.00filing
4 Apr 2012filed 5 Apr 2012Broadcast InternationalSEC FORM 4 Bought$36K144,000 at $0.25filing
1 Sep 2011filed 6 Sep 2011Graphon Corp/deoption or derivativeSEC FORM 4 Code P—625,000 at $0.00filing
1 Sep 2011filed 6 Sep 2011Graphon Corp/deSEC FORM 4 Bought$250K1,250,000 at $0.20filing
9 Aug 2011filed 16 Aug 2011Graphon Corp/deoption or derivativeSEC FORM 4 Code A—400,000 at $0.00filing
29 Jul 2010filed 18 Aug 2010ACFN Acorn Energyoption or derivative · Professional ServicesSEC FORM 4 Code A—25,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Farrell SimonDirector · Director at Serina Therapeutics, filing Form 4 there in the last year
Stephen K. BrannanDirector · Director at Serina Therapeutics, filing Form 4 there in the last year
Richard Peter MarshallDirector · Director at Serina Therapeutics, filing Form 4 there in the last year
Karen J. WilsonDirector · Director at Serina Therapeutics, filing Form 4 there in the last year
Gregory BaileyDirector · Director at Serina Therapeutics, filing Form 4 there in the last year